The Netherlands Chlamydia Cohort Study: assessing the risk of late complications after Chlamydia trachomatis infection in wome

Recruiting

• Conditions: Chlamydia; Chlamydia trachomatis; 10008555; 10010273; 10033283

• Registration Number: NL-OMON55823
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 14685

Inclusion Criteria

- Being a women;
- Participated in at least one round of the Chlamydia Screening Implementation
between 2008 and 2011;
- Given informed consent in the Chlamydia Screening Implementation to be
contacted again for future STI-related research.

Exclusion Criteria

- Not living in the Netherlands anymore;
- No traceable address information.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main outcomes of the study are PID, ectopic pregnancy, tubal infertility<br /><br>and time to pregnancy. The primary study parameter is the presence of a<br /><br>previous Ct infection. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary study parameters include candidate host genetic biomarkers (SNPs)<br /><br>and behavioural, demographic, and pathogen factors possibly associated with the<br /><br>development of Ct related complications. </p><br>